Role of physical activity for weight loss and weight maintenance
Novo Nordisk, the parent company of Wegovy, told Newsweek that this study "highlights the chronic nature of obesity and suggest that ongoing treatment is necessary." Eli Lilly and Company, the parent company of Mounjaro, told Newsweek : "When treatment is stopped, weight can return, which reflects the biology of the condition rather than a lack of effort." Newsweek reached out to the Centers for Disease Control and Prevention (CDC) via email for comment
Novo Nordisk PAP Novo Nordisks PAP is designed to help those who dont have commercial insurance and otherwise cant afford their medications
It is advisable for a person to discuss options with their healthcare professional
Tirzepatides dual agonism of GIP and GLP-1 receptors allows for enhanced glycemic control and appetite regulation
"As effective as GLP-1 medications are, many people stop taking them because of cost, side effects or simply not wanting to take a drug long-term," said lead author Shelby Sullivan, MD, director of the Endoscopic Bariatric and Metabolic Program at Dartmouth Health Weight Center and professor of medicine, Dartmouth Geisel School of Medicine
